Company
Merck
Merck is a multinational pharmaceutical company that develops, manufactures, and markets a wide range of medicines, vaccines, and animal health products.
Why it’s in the news: It is in the news due to positive late-stage trial results for its mRNA cancer vaccine and its licensing deals for an HIV prevention pill.
Latest on Merck
- Moderna, Merck breakthrough could usher in wave of cancer vaccines
- mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
- Merck, Moderna claim encouraging melanoma vaccine trial results
- STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
- Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck
- STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
- 13F: First Nebraska Trust holds Merck ($11M)
- 13F: Advisors Asset Management holds Merck ($34M)
- 13F: 49 Wealth Management Llc holds Merck ($1M)
- Wikidata: Merck — located in — Germany
- Wikidata: Merck — capital ownership — Seven Seas Limited
- Wikidata: Merck — capital ownership — Merck (India)
Connections
50 entities linked to Merck across the news graph.
Also connected to (50)
GermanySeven Seas LimitedMerck (India)Merck (United Kingdom)Merck SLMerck (Canada)Merck Seronochemical industrypharmaceutical industrymanufacture of pharmaceutical preparationsHeinrich Emanuel MerckCarl MerckFriedrich Jacob MerckWilhelm MerckGeorg MerckBelén GarijoLinscomb WealthXml Financial LlcMartin Investment Management LlcProcessus Wealth & Capital Management LlcAdvisors Asset ManagementHealth Care Roundup: Market TalkBond Yields Dive After Treasury Increases BuybacksModerna, Merck breakthrough could usher in wave of cancer vaccines